IL2 and type 1 diabetes mellitus: Interleukin-2 (IL-2) is critical for maintaining the function of the CD4+ regulatory T cells (Tregs), which in turn regulate autoreactive CD4+ effector T cells (Teffs) to prevent autoimmune diseases, such as T1D (61, 62).